Novel nonhallucinogenic DMT analogues as drug candidates for mental health and addiction disorders March 28, 2022
Identification of sites of metabolic liability for KRM-II-81 and evaluation of a deuterated analogue March 28, 2022
Cyclica and Arctoris expand partnership to progress drug discovery in Alzheimer's disease March 24, 2022
Discovery of vilazodone-donepezil chimeras for the treatment of AD with comorbid depression March 24, 2022
New Merck & Co. LRRK2 inhibitors show good drug properties for treating Parkinson's disease March 23, 2022
RSS